1183-P: Utilization of Low vs. High Dose of Newer Antihyperglycemic Agents
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-1183-p
Abstract: Evidence from clinical trials suggest that newer antihyperglycemic agents (AHAs) have a better clinical profile at a higher dose. However, the utilization of the different doses in the real world is not well known. This… read more here.
Keywords: antihyperglycemic agents; high dose; newer antihyperglycemic; dose ... See more keywords